Question # 4 (Multiple Answer) Biguanides: clinical uses & advantages:
(A) does not increase weight
(B) does not cause hypoglycemia
(C) used in patients with refractory obesity
(D) used in patients with insulin resistance
BACK
Question # 5 (Multiple Answer) oral hypoglycemics: categories
(A) sulfonylureas -- glipizide (Glucotrol)
(B) biguanides -- metformin (Glucophage)
(C) alpha glucosidase inhibitor -- actor boasts
(D) thiozolidinediones -- rosiglitazone (Avandia)
BACK
Question # 10 (Multiple Answer) Troglitazone (Rezulin):
(A) withdrawn for use as monotherapy
(B) approved for use in insulin-resistant patients receiving insulin
(C) increases tissue insulin sensitivity
(D) may cause rare, but occasionally lethal liver dysfunction
BACK
Question # 12 (Multiple Answer) Characteristics of autonomic neuropathy associated with diabetes:
(A) syncope
(B) cardiopulmonary arrest
(C) orthostatic hypotension
(D) constipation or diarrhea
(E) esophageal dysfunction
BACK